Bacil Pharma Ltd — Important, 13-01-2026: Company Update

BACIL PHARMA has confirmed its efficient handling of share dematerialization for the quarter ending December 31. The company's Registrar and Transfer Agent reported that all securities received for conversion into electronic form were properly processed and listed on stock exchanges. Physical certificates were cancelled, and the depository's name was updated in company records as the registered owner. This ensures smooth and compliant management of investor holdings, reinforcing operational integrity for shareholders.